Categories: News

Cryo Sculpting Lab Announces Revolutionary Franchise Opportunity in Non-Invasive Body Contouring

SAN DIEGO, June 21, 2024 /PRNewswire/ — Cryo Sculpting Lab (CSL), a pioneer in non-invasive body contouring, is excited to announce its new franchise opportunity, offering entrepreneurs a chance to own a business in the rapidly growing health and wellness industry. Specializing in cutting-edge fat freezing treatments, CSL provides a proven business model designed for high profitability and scalability.

The CSL franchise requires a minimal initial investment, starting at just $49,750, which includes a state-of-the-art cryo sculpting machine and an $18,000 franchise fee. Entrepreneurs can begin operations in a compact 150-square-foot space, such as a private suite or shared salon, eliminating the need for large, costly build-outs.

“Our mission is to empower franchise owners by keeping startup costs low and providing a flexible, scalable business model,” said David Krainiak, CEO of Cryo Sculpting Lab. “With our transparent fixed monthly fees, franchisees retain more of their earnings, ensuring their success aligns with the growth of their business.”

CSL offers comprehensive support to franchisees, including site selection, store design, and a thorough training program. This ensures that new franchise owners can open their doors in as little as 30 days post-training. The business model supports a single owner/operator setup, streamlining operations and reducing payroll complexities.

A standout feature of the CSL franchise is its Recurring Revenue system. By selling memberships, franchisees can secure a steady income stream, often starting their day with substantial earnings from these pre-sold memberships. This model offers financial stability and predictability, setting CSL apart from other franchises.

Cryo Sculpting Lab’s innovative treatments are designed to be accessible to a broad customer base, making formerly exclusive body contouring services affordable for everyone. The treatments, which last 46 minutes, target common problem areas such as the belly, love handles, and arms without the need for needles, surgery, or downtime.

“We are thrilled to offer this unique opportunity to entrepreneurs who are passionate about health and wellness,” added David Krainiak. “With our support and proven business model, franchisees can quickly establish a profitable business while helping their clients achieve their body goals.”

For more information on owning a Cryo Sculpting Lab franchise, visit https://franchise.cryosculptinglab.com or contact CSLFranchising@gmail.com.

About Cryo Sculpting Lab
Cryo Sculpting Lab is a leader in non-invasive body contouring, offering innovative fat-freezing treatments. With a focus on affordability and accessibility, CSL provides franchise opportunities designed for success in the growing wellness industry.

View original content to download multimedia:https://www.prnewswire.com/news-releases/cryo-sculpting-lab-announces-revolutionary-franchise-opportunity-in-non-invasive-body-contouring-302179327.html

SOURCE Cryo Sculpting Lab

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

6 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

7 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

7 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

8 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

10 hours ago